![Alex Trebeks Cbd Gummies: A Practical Look At The Celebrity Linked Trend [zydRGYwbdTp]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/06/ced-pexels-5469158.jpg?resize=150%2C150&ssl=1 "Alex Trebeks Cbd Gummies: A Practical Look At The Celebrity Linked Trend 19")
![Cbd Gummies Supplement: A Practical Guide For Everyday Wellness [QHSCtaspdLc]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/06/ced-pexels-7883504.jpg?resize=150%2C150&ssl=1 "Cbd Gummies Supplement: A Practical Guide For Everyday Wellness 20")
![B+cbd Gummies For Metabolic Balance And Daily Wellness [3s5LqrrZ748]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/06/ced-pexels-3259579.jpg?resize=150%2C150&ssl=1 "B+cbd Gummies For Metabolic Balance And Daily Wellness 29")
![An In Depth Review Of Cbd Gummies Relax Nanocraftcbd [OLeO1jbOoaI]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/06/ced-pexels-8670032.jpg?resize=150%2C150&ssl=1 "An In Depth Review Of Cbd Gummies Relax Nanocraftcbd 30")
Cannabis for Endometriosis Pain: Insights from a 2-Year UK Registry
A 2-year UK registry study on cannabis endometriosis pain relief followed 101 women, revealing significant improvements in pain, quality of life, sleep, and anxiety. The study also noted a trend toward reduced opioid use. While promising, this…
Cannabis Science Digest: Driving Behavior, CBD Use, and Emotional Processing
Cannabis science digest findings describe driving behavior, public CBD use, and emotional processing after short abstinence. The studies offer human evidence signals while retaining important simulator, survey, and pilot-design limits. None proves a…
Adolescent Cannabis Use and Its Impact on Cognitive Development: Insights from the ABCD Study
The ABCD Study reveals adolescent cannabis use cognitive development risk, showing teens who use cannabis experience slower gains in memory, attention, and executive function. This prospective evidence highlights the importance of understanding cannabis…
Emergency Department Visits for Cannabis Hyperemesis Syndrome Surge in Young Adults: CDC Surveillance 2023-2026
Cannabis hyperemesis syndrome diagnosis is increasingly recognized in emergency departments, with CDC data showing a surge in visits among young adults. Improved diagnostic coding since 2025 reveals a true clinical and public health concern. Awareness…
Evidence for Cannabis Treatment Improving Core Autism Symptoms
This article reviews cannabis autism treatment evidence from a Phase II/III trial of NTI164, a low-THC full-spectrum medicinal cannabis extract. The trial demonstrated significant improvements in core autism symptoms, adaptive functioning, and social…
Cannabis Oil for Parkinson’s Pain: What a 101-Person Randomized Trial Found
cannabis oil Parkinson’s pain randomized trial: A phase II randomized placebo-controlled trial enrolled 101 people with Parkinson’s disease and chronic pain to test a CBD-dominant cannabis oil for nine weeks. The study found no significant advantage over…
What the Latest Dronabinol PTSD Nightmares Clinical Trial Reveals
A recent dronabinol PTSD nightmares clinical trial involving 171 adults demonstrated that this FDA-approved synthetic THC medication significantly reduces nightmare frequency and intensity. The trial highlights dronabinol's targeted effect on…
2026 Review: Cannabinoids in Managing MS Spasticity
This 2026 systematic review evaluates cannabinoids for MS spasticity, finding modest improvements with THC:CBD extracts. Despite low evidence certainty, cannabinoids may aid some patients with MS spasticity as adjunctive therapy. Careful clinical…
Clinical Efficacy of Dronabinol for PTSD Nightmares: Insights from a 171-Person Trial
A 171-person randomized controlled trial demonstrates dronabinol PTSD nightmares clinical efficacy, significantly reducing nightmare frequency and intensity. This FDA-approved synthetic THC medication offers targeted relief for PTSD-related nightmares…
The DEA Rescheduling Hearing Is Over. A New Commentary Argues States Should Lead the Next Phase of Cannabis Research
The DEA rescheduling hearing has concluded, but the clinical benefits depend on state cannabis research policy. States with mature medical programs must build infrastructure to convert lowered federal barriers into usable clinical evidence. This…